Is There A Benefit Of Oxaliplatin In Neoadjuvant Treatment Of Locally Advanced Rectal Cancer? An Updated Meta-Analysis.

JOURNAL OF CLINICAL ONCOLOGY(2020)

Cited 5|Views23
No score
Abstract
4098Background: Neoadjuvant fluoropyrimidine (5FU or capecitabine)-based chemoradiotherapy (CRT) has been considered the standard of care for locally advanced rectal cancer (LARC). Whether addition...
More
Translated text
Key words
Neoadjuvant Therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined